CoQ10 supplement for women starting IVF
Part of Women’s health & pregnancy clinical trials.
This trial tests two forms of coenzyme Q10 (ubiquinone vs. ubiquinol) to see if either improves egg quality or IVF success. It may be a good fit if you are between 37 and 43, doing your first IVF cycle, and have certain hormone levels within a normal range.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 37 and 43 years old, doing your first IVF cycle.
- Your day 3 FSH is less than 12, with normal estradiol, TSH, and prolactin levels.
- Your partner's sperm is suitable for IVF or ICSI.
- Your AMH level is above 3 pmol/L.
- You have a normal uterine cavity (no polyps or fibroids affecting the cavity).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking coenzyme Q10 before in vitro fertilization (IVF) can improve egg quality and increase the chances of a successful pregnancy for women with a low ovarian response. It may help if you have had few eggs retrieved in past IVF cycles or have low ovarian reserve.
This trial tests whether taking NMN (a form of vitamin B3) can help improve the quality of embryos in women who have had previous IVF failures due to poor embryo development.
This trial tests whether taking alpha-lipoic acid (an antioxidant supplement) before and during IVF can improve pregnancy success in women aged 35–45 using their own eggs. It aims to see if the supplement can help counter age-related declines in egg quality.
This study tests different medication approaches to help women who had a low number of eggs in a previous IVF cycle produce more eggs this time. The goal is to find a better stimulation method for women with this 'low response' pattern.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
This trial tests whether adding a personalized amount of “LH” during IVF hormone stimulation can help your ovaries respond better. It may be useful if you’ve had a weaker IVF response before and fit specific age and egg-quality markers.
Hear when a new IVF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.